Ars Pharmaceuticals Inc (SPRY)

08:01 AM

ARS Pharmaceuticals (NASDAQ: SPRY) to Host Q3 Results Webcast; Replay for 30 Days - Stock Titan

08:01 AM

08:00 AM

ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results - GlobeNewswire

08:00 AM

07:50 AM

ARS Pharma Presents Late-Breaking Oral and Poster Sessions on Real-World Effectiveness of neffy® at ACAAI 2025 Annual Scientific Meeting - Quiver Quantitative

07:50 AM

07:45 AM

ARS Pharmaceuticals Inc. stock outlook for YEAR2025 Short Interest & Reliable Momentum Entry Alerts - newser.com

07:45 AM

07:45 AM

ARS Pharma (Nasdaq: SPRY) shares 9 of 10 anaphylaxis cases treated with single-dose neffy - Stock Titan

07:45 AM

05:45 AM

Why ARS Pharmaceuticals Inc. stock could see breakout soonIPO Watch & Free Technical Pattern Based Buy Signals - newser.com

05:45 AM

05:35 AM

Will ARS Pharmaceuticals Inc. stock maintain momentum in 2025Weekly Investment Recap & Technical Pattern Based Signals - newser.com

05:35 AM

03:47 AM

Why ARS Pharmaceuticals Inc. stock could rally in 2025Market Sentiment Review & Long-Term Growth Plans - newser.com

03:47 AM

02:50 AM

Will ARS Pharmaceuticals Inc. rebound enough to break evenWeekly Profit Recap & AI Driven Price Predictions - newser.com

02:50 AM

02:44 AM

Applying chart zones and confluence areas to ARS Pharmaceuticals Inc.Weekly Gains Report & Weekly Market Pulse Alerts - newser.com

02:44 AM

Nov 02, 2025

Why ARS Pharmaceuticals Inc. stock could outperform in 2025Market Sentiment Report & Short-Term High Return Strategies - newser.com

Nov 02, 2025

Nov 02, 2025

Why ARS Pharmaceuticals Inc. stock is recommended by analystsTrade Volume Summary & Growth Focused Investment Plans - newser.com

Nov 02, 2025

Nov 02, 2025

Published on: 2025-11-02 04:08:25 - newser.com

Nov 02, 2025

Nov 01, 2025

Custom strategy builders for tracking ARS Pharmaceuticals Inc.Quarterly Profit Report & Free Technical Pattern Based Buy Signals - newser.com

Nov 01, 2025

Nov 01, 2025

Multi factor analysis applied to ARS Pharmaceuticals Inc.Earnings Recap Report & Expert Approved Momentum Trade Ideas - newser.com

Nov 01, 2025

Nov 01, 2025

How ARS Pharmaceuticals Inc. stock reacts to inflationary pressuresJuly 2025 Outlook & Precise Trade Entry Recommendations - newser.com

Nov 01, 2025

Nov 01, 2025

How ARS Pharmaceuticals Inc. stock trades during market volatilityGap Up & Daily Oversold Bounce Ideas - newser.com

Nov 01, 2025

Nov 01, 2025

Published on: 2025-11-01 01:27:58 - newser.com

Nov 01, 2025

Oct 31, 2025

ARS Pharmaceuticals (NASDAQ:SPRY) Hits New 52-Week LowWhat's Next? - MarketBeat

Oct 31, 2025

Oct 31, 2025

How ARS Pharmaceuticals Inc. stock valuations compare to rivalsWeekly Stock Recap & Low Drawdown Investment Ideas - newser.com

Oct 31, 2025

Oct 31, 2025

Trend analysis for ARS Pharmaceuticals Inc. this weekMarket Weekly Review & Momentum Based Trading Ideas - newser.com

Oct 31, 2025

Oct 31, 2025

Reversal indicators forming on ARS Pharmaceuticals Inc. stockWeekly Stock Summary & High Accuracy Investment Entry Signals - newser.com

Oct 31, 2025

Oct 31, 2025

Is ARS Pharmaceuticals Inc. stock supported by innovation pipelineJuly 2025 Catalysts & Community Trade Idea Sharing Platform - newser.com

Oct 31, 2025

Oct 31, 2025

Is ARS Pharmaceuticals Inc. a candidate for recovery playWeekly Stock Report & AI Forecasted Entry/Exit Points - newser.com

Oct 31, 2025

Oct 30, 2025

ARS Pharmaceuticals Hits New 52-Week Low at $8.90 Amid Financial Struggles - Markets Mojo

Oct 30, 2025

Oct 29, 2025

Ars Pharmaceuticals’ Latest Study: A Potential Game-Changer in Allergy Treatment - MSN

Oct 29, 2025

Oct 28, 2025

Can ARS Pharmaceuticals Inc. stock sustain revenue growthWeekly Stock Summary & Daily Risk Controlled Trade Plans - Fundação Cultural do Pará

Oct 28, 2025